Bank of New York Mellon’s VolitionRx Ltd VNRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,780
| Closed | -$11.2K | – | 4439 |
|
|
2026
Q1 | $11.2K | Hold |
2,780
| – | – | ﹤0.01% | 4185 |
|
|
2025
Q4 | $14.2K | Buy |
2,780
+1,250
| +82% | +$9.49K | ﹤0.01% | 4173 |
|
|
2025
Q3 | $20.8K | Hold |
1,530
| – | – | ﹤0.01% | 4160 |
|
|
2025
Q2 | $23.3K | Hold |
1,530
| – | – | ﹤0.01% | 4108 |
|
|
2025
Q1 | $17.4K | Buy |
+1,530
| New | +$18.2K | ﹤0.01% | 4093 |
|
|
2024
Q1 | – | Sell |
-1,047
| Closed | -$15K | – | 4319 |
|
|
2023
Q4 | $15K | Sell |
1,047
-11
| -1% | -$162 | ﹤0.01% | 4253 |
|
|
2023
Q3 | $14.6K | Sell |
1,058
-19
| -2% | -$470 | ﹤0.01% | 4272 |
|
|
2023
Q2 | $29.9K | Sell |
1,077
-4
| -0.4% | -$132 | ﹤0.01% | 4242 |
|
|
2023
Q1 | $41.3K | Hold |
1,081
| – | – | ﹤0.01% | 4225 |
|
|
2022
Q4 | $52.6K | Sell |
1,081
-6
| -0.6% | -$233 | ﹤0.01% | 4229 |
|
|
2022
Q3 | $30K | Hold |
1,087
| – | – | ﹤0.01% | 4397 |
|
|
2022
Q2 | $45K | Sell |
1,087
-4
| -0.4% | -$201 | ﹤0.01% | 4367 |
|
|
2022
Q1 | $66K | Hold |
1,091
| – | – | ﹤0.01% | 4481 |
|
|
2021
Q4 | $69K | Hold |
1,091
| – | – | ﹤0.01% | 4457 |
|
|
2021
Q3 | $68K | Sell |
1,091
-27
| -2% | -$1.71K | ﹤0.01% | 4392 |
|
|
2021
Q2 | $74K | Sell |
1,118
-3,380
| -75% | -$229K | ﹤0.01% | 4266 |
|
|
2021
Q1 | $340K | Buy |
4,498
+202
| +5% | +$17.3K | ﹤0.01% | 3857 |
|
|
2020
Q4 | $334K | Buy |
4,296
+441
| +11% | +$30.4K | ﹤0.01% | 3786 |
|
|
2020
Q3 | $248K | Sell |
3,855
-12
| -0.3% | -$816 | ﹤0.01% | 3776 |
|
|
2020
Q2 | $301K | Buy |
3,867
+2,549
| +193% | +$184K | ﹤0.01% | 3690 |
|
|
2020
Q1 | $82K | Sell |
1,318
-13
| -1% | -$1.08K | ﹤0.01% | 3893 |
|
|
2019
Q4 | $126K | Sell |
1,331
-68
| -5% | -$7.05K | ﹤0.01% | 3993 |
|
|
2019
Q3 | $157K | Hold |
1,399
| – | – | ﹤0.01% | 3953 |
|
|
2019
Q2 | $88K | Hold |
1,399
| – | – | ﹤0.01% | 4046 |
|
|
2019
Q1 | $91K | Sell |
1,399
-47
| -3% | -$2.62K | ﹤0.01% | 4018 |
|
|
2018
Q4 | $52K | Buy |
1,446
+929
| +180% | +$44.2K | ﹤0.01% | 4056 |
|
|
2018
Q3 | $27K | Hold |
517
| – | – | ﹤0.01% | 4191 |
|
|
2018
Q2 | $21K | Sell |
517
-320
| -38% | -$14.3K | ﹤0.01% | 4167 |
|
|
2018
Q1 | $40K | Buy |
837
+320
| +62% | +$18.7K | ﹤0.01% | 4195 |
|
|
2017
Q4 | $30K | Sell |
517
-1,002
| -66% | -$58.6K | ﹤0.01% | 4264 |
|
|
2017
Q3 | $80K | Hold |
1,519
| – | – | ﹤0.01% | 4036 |
|
|
2017
Q2 | $108K | Buy |
1,519
+971
| +177% | +$70K | ﹤0.01% | 4013 |
|
|
2017
Q1 | $45K | Buy |
548
+31
| +6% | +$2.74K | ﹤0.01% | 4150 |
|
|
2016
Q4 | $47K | Buy |
+517
| New | +$46.4K | ﹤0.01% | 4138 |
|
|
2016
Q3 | – | Sell |
-518
| Closed | -$32K | – | 4321 |
|
|
2016
Q2 | $32K | Buy |
518
+4
| +0.8% | +$276 | ﹤0.01% | 4238 |
|
|
2016
Q1 | $36K | Hold |
514
| – | – | ﹤0.01% | 4119 |
|
|
2015
Q4 | $46K | Hold |
514
| – | – | ﹤0.01% | 4199 |
|
|
2015
Q3 | $46K | Buy |
+514
| New | +$39.5K | ﹤0.01% | 4253 |
|
Other funds holding VNRX
LIM
LM
WANY
XT
Bank of New York Mellon's VNRX Position: Q2 2026 in Review
Bank of New York Mellon sold out of VolitionRx Ltd (VNRX) in Q2 2026, closing a stake of 2,780 shares — an estimated $11.2K sold.
Bank of New York Mellon first reported a position in VNRX in Q3 2015 and held it in 38 quarters. The position peaked at $340K in Q1 2021. 24 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.
- Bank of New York Mellon reported no remaining VolitionRx Ltd position as of Q2 2026 after selling out during the quarter.
- Bank of New York Mellon sold 2,780 VolitionRx Ltd shares in Q2 2026, an estimated $11.2K.
- Bank of New York Mellon first reported a position in VolitionRx Ltd in Q3 2015 and held it in 38 quarters.
- Bank of New York Mellon's VolitionRx Ltd position peaked at $340K in Q1 2021.
- 24 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.